The MYL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MYL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MYL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View MYL Detailed Price Forecast - CNN Money||View MYL Detailed Summary - Google Finance|
|View MYL Detailed Summary - Yahoo! Finance||View MYL Stock Research & Analysis - Zacks.com|
|View MYL Trends & Analysis - Trade-Ideas||View MYL Major Holders - Barrons|
|View MYL Call Transcripts - NASDAQ||View MYL Breaking News & Analysis - Seeking Alpha|
|View MYL Annual Report - CompanySpotlight.com||View MYL OTC Short Report - OTCShortReport.com|
|View MYL Fundamentals - TradeKing||View MYL SEC Filings - Bar Chart|
|View Historical Prices for MYL - The WSJ||View Performance/Total Return for MYL - Morningstar|
|View the Analyst Estimates for MYL - MarketWatch||View the Earnings History for MYL - CNBC|
|View the MYL Earnings - StockMarketWatch||View MYL Buy or Sell Recommendations - MacroAxis|
|View the MYL Bullish Patterns - American Bulls||View MYL Short Pain Metrics - ShortPainBot.com|
|View MYL Stock Mentions - StockTwits||View MYL Stock Mentions - PennyStockTweets|
|View MYL Stock Mentions - Twitter||View MYL Investment Forum News - Investor Hub|
|View MYL Stock Mentions - Yahoo! Message Board||View MYL Stock Mentions - Seeking Alpha|
|View Insider Transactions for MYL - SECform4.com||View Insider Transactions for MYL - Insider Cow|
|View MYL Major Holdings Summary - CNBC||View Insider Disclosure for MYL - OTC Markets|
|View Insider Transactions for MYL - Yahoo! Finance||View Institutional Holdings for MYL - NASDAQ|
|View MYL Stock Insight & Charts - FinViz.com||View MYL Investment Charts - StockCharts.com|
|View MYL Stock Overview & Charts - BarChart||View MYL User Generated Charts - Trading View|
Theravance, Mylan Report Positive Data on COPD Drug Yupelri
Posted on Tuesday September 18, 2018
Theravance (TBPH) and partner Mylan post positive data from a late-stage program on COPD Drug, Yupelri.
Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI™ (revefenacin) in Oral Presentation at the European Respiratory Society International Congress
Posted on Monday September 17, 2018
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Sept. 17, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma") and Mylan N.V. (MYL) ("Mylan") today announced that positive new data from the companies' Phase 3 clinical program for YUPELRI™ (revefenacin) inhalation solution were featured in an oral presentation at the European Respiratory Society (ERS) International Congress 2018, which is being held in Paris, France on September 15-19, 2018. Presented data showed reductions in the rates of chronic obstructive pulmonary disease (COPD) exacerbations ranging from 15% to 18% in moderate to very severe COPD patients administered once-daily YUPELRI for up to 52 weeks as compared to placebo and tiotropium (Spiriva® HandiHaler®). While the YUPELRI Phase 3 program was not designed or powered to achieve statistical significance on differences in COPD exacerbation rates, researchers were interested in a post-hoc analysis of data from the studies to identify trends in this area.
The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Posted on Sunday September 16, 2018
Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction ...
See what the IHS Markit Score report has to say about Mylan NV.
Posted on Saturday September 15, 2018
Mylan NV NASDAQ/NGS:MYL